drug

Cognitive battery

as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
BEHAVIORAL
Pre-approval / investigational in the US
Developed by Fundación Marques de Valdecilla
1 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
BEHAVIORAL

Indications

Trials

1
Neurocognitive Effectiveness in Treatment of First-episode Non-affective Psychosis: 1-year Follow-up
NCT02534363Phase 4Completed

KOLs & investigators

1
Benedicto Crespo-Facorro, ProfessorKOL score 12

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
Fundación Marques de Valdecilla
company
trial
Neurocognitive Effectiveness in Treatment of First-episode Non-affective Psychosis: 1-year Follow-up
PHASE4
trial
indication
Schizophrenia
indication
Schizophrenia
indication
Psychotic Disorders
indication
Psychotic Disorders
indication
KOL
Benedicto Crespo-Facorro, Professor
KOL score 12
person